58 employees
Elite Pharmaceuticals develops oral controlled-release products for the pain management, allergy, cardiovascular, and infection areas.
1996
$800K
from 1 investors over 1 rounds
Elite Pharmaceuticals, Inc. raised $800K on April 15, 2014
Investors: Lincoln Park Capital, LLC